2021-2022年流感季美国加利福尼亚州COVID-19疫苗与季节性流感疫苗的接种情况
该研究对2021年10月22日至2022年6月22日招募的1261名接受SARS-CoV-2检测者进行病例对照研究的二次分析,评估2021-2022年流感疫苗接种的预测因素。43%同时接种流感疫苗和至少1剂COVID-19疫苗,34%仅接种COVID-19疫苗,4%仅接种流感疫苗,19%两者均未接种。接种至少1剂COVID-19疫苗与流感疫苗接种相关(aOR=3.72,95%CI 2.15-6.43),在接种至少1剂COVID-19加强针者中关联更强(aOR=16.50,95%CI 10.10-26.97);SARS-CoV-2检测阳性者接种流感疫苗的比值较低(aOR=0.64,95%CI 0.50-0.82)。
要点
- 43%同时接种流感疫苗和至少1剂COVID-19疫苗,34%仅接种COVID-19疫苗,4%仅接种流感疫苗,19%两者均未接种。
- 接种至少1剂COVID-19疫苗与流感疫苗接种相关(aOR=3.72,95%CI 2.15-6.43)。
- SARS-CoV-2检测阳性者接种流感疫苗的比值较低(aOR=0.64,95%CI 0.50-0.82)。
核心结论
- 接种COVID-19疫苗者更可能在2021-2022流感季接种季节性流感疫苗。
- SARS-CoV-2检测阳性者接种季节性流感疫苗的可能性较低,提示可在COVID-19诊断前后提供流感疫苗接种机会。
研究设计与样本
- 对一项招募接受SARS-CoV-2检测者的病例对照研究数据进行二次分析。
- 采用混合效应逻辑回归估计与季节性流感疫苗接种相关的因素。
- 构建多项调整边际概率模型,比较仅接种COVID-19疫苗、仅接种季节性流感疫苗或两者均接种相对于两者均未接种的情况。
- 2021年10月22日至2022年6月22日招募1261名符合条件的参与者。
主要发现
- 43%(545人)同时接种季节性流感疫苗和至少1剂COVID-19疫苗,34%(426人)仅接种至少1剂COVID-19疫苗,4%(49人)仅接种季节性流感疫苗,19%(241人)两者均未接种。
- 接种至少1剂COVID-19疫苗与季节性流感疫苗接种相关(aOR=3.72,95%CI 2.15-6.43)。
- 在接种至少1剂COVID-19加强针的参与者中该关联更强(aOR=16.50,95%CI 10.10-26.97)。
- 与SARS-CoV-2检测阴性者相比,检测阳性者接种2021-2022季节性流感疫苗的比值较低(aOR=0.64,95%CI 0.50-0.82)。
临床怎么用
- 作者认为,SARS-CoV-2检测阳性者接种季节性流感疫苗的可能性较低,提示可在COVID-19诊断前后提供流感疫苗接种机会。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite lower circulation of influenza virus throughout 2020-2022 during the COVID-19 pandemic, seasonal influenza vaccination has remained a primary tool to reduce influenza-associated illness and death. The relationship between the decision to receive a COVID-19 vaccine and/or an influenza vaccine is not well understood. METHODS: We assessed predictors of receipt of 2021-2022 influenza vaccine in a secondary analysis of data from a case-control study enrolling individuals who received SARS-CoV-2 testing. We used mixed effects logistic regression to estimate factors associated with receipt of seasonal influenza vaccine. We also constructed multinomial adjusted marginal probability models of being vaccinated for COVID-19 only, seasonal influenza only, or both as compared with receipt of neither vaccination. RESULTS: Among 1261 eligible participants recruited between 22 October 2021-22 June 2022, 43% (545) were vaccinated with both seasonal influenza vaccine and >1 dose of a COVID-19 vaccine, 34% (426) received >1 dose of a COVID-19 vaccine only, 4% (49) received seasonal influenza vaccine only, and 19% (241) received neither vaccine. Receipt of >1 COVID-19 vaccine dose was associated with seasonal influenza vaccination (adjusted odds ratio [aOR]: 3.72; 95% confidence interval [CI]: 2.15-6.43); this association was stronger among participants receiving >1 COVID-19 booster dose (aOR = 16.50 [10.10-26.97]). Compared with participants testing negative for SARS- CoV-2 infection, participants testing positive had lower odds of receipt of 2021-2022 seasonal influenza vaccine (aOR = 0.64 [0.50-0.82]). CONCLUSIONS: Recipients of a COVID-19 vaccine were more likely to receive seasonal influenza vaccine during the 2021-2022 season. Factors associated with individuals' likelihood of receiving COVID-19 and seasonal influenza vaccines will be important to account for in future studies of vaccine effectiveness against both conditions. Participants who tested positive for SARS-CoV-2 in our sample were less likely to have received seasonal influenza vaccine, suggesting an opportunity to offer influenza vaccination before or after a COVID-19 diagnosis.
引用
- Andrejko KL, Myers JF, Openshaw J, et al. Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season. Vaccine. 2022. PMID: 36585281. doi:10.1016/j.vaccine.2022.12.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。